<qa>  What is the purpose of the study?gpASITTM product is based on highly purified allergen fragments obtained from grass pollen. The purpose of this study is to demonstrate the clinical efficacy and safety of a subcutaneous immunotherapy with gpASITTM in patients with grass pollen-induced allergic rhinoconjunctivitis compared to placebo. 